Clinical concerns of alendronate use.
Rutkowski
James L
JL
Johnson
David A
DA
Smith
Douglas M
DM
D019386:Alendronate / Q000008:administration & dosage / Q000009:adverse effects*; D050071:Bone Density Conservation Agents / Q000008:administration & dosage / Q000009:adverse effects*; D016723:Bone Remodeling / Q000187:drug effects; D000075202:Contraindications; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007571:Jaw Diseases / Q000139:chemically induced*; D019647:Oral Surgical Procedures; D010020:Osteonecrosis / Q000139:chemically induced*
D050071:Bone Density Conservation Agents; D019386:Alendronate